GlassScriptPhysician profile
Ehud Mendel
NPI 1275561342
$119,906.94
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $670 · 2022: $20K · 2023: $18K · 2024: $20K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $57K · Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $56,833.55 |
| Food and Beverage | $1,404.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $81,499.40 | 2019-2025 | Capri Corpectomy Cage System |
| Vb Spine LLC | $15,604.19 | 2025 | Capri Corpectomy Cage System |
| Medical Device Business Services, INC. | $12,103.66 | 2019-2020 | |
| Depuy Synthes Products, INC. | $4,680.00 | 2019 | |
| Varian Medical Systems, INC. | $4,365.85 | 2019 | |
| Medtronic, INC. | $404.00 | 2023-2025 | Mazor X System, O-Arm, Cd Horizon Spinal System |
| Carbofix Spine INC | $388.70 | 2023-2025 | |
| Depuy Synthes Sales INC. | $328.02 | 2019-2024 | Expedium, Symphony, Teligen |
| Pacira Pharmaceuticals Incorporated | $203.94 | 2023 | Exparel, Iovera, Zilretta |
| Globus Medical, INC. | $125.00 | 2019 | |
| Icotec Medical INC. | $108.95 | 2024 | Vader Pedicle System |
| Kuros Biosciences USA, INC | $95.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehud Mendel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.